MetaCap

Century Therapeutics Insider Trades

NASDAQ: IPSCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.47+0.01 (+0.68%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $49.25K
Sales
15 · $68.13K
Shares bought / sold
58.06K / 28.75K
Net activity
Net selling $18,875

Century Therapeutics insider activity

Over the last 12 months, Century Therapeutics insiders reported 33 transactions on SEC Form 4: 1 open-market purchase and 15 sales. Insiders bought $49,252 and sold $68,127 worth of stock, for net insider selling of $18,875. The largest seller was Russotti Gregory, with $39,860 in reported sales.

The most recent filing shows Russotti Gregory (See Remarks) selling 2,587 shares at $1.93 on Sep 14, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IPSC's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

IPSC insider transactions

Century Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 14, 2026Carr DouglasSVP Finance & OperationsSale1,658$3.20KForm 4
Sep 14, 2026Russotti GregorySee RemarksSale2,587$4.99KForm 4
Sep 11, 2026Pfeiffenberger BrentPresident and CEOTax withholding13,850$26.87KForm 4
Sep 8, 2026Carr DouglasSVP Finance & OperationsSale254$520.70Form 4
Sep 8, 2026Russotti GregorySee RemarksSale534$1.09KForm 4
Sep 4, 2026Pfeiffenberger BrentPresident and CEOTax withholding463$976.93Form 4
Aug 14, 2026Pfeiffenberger BrentPresident and CEOTax withholding31,172$59.85KForm 4
Aug 3, 2026Carr DouglasSVP Finance & OperationsSale275$543.68Form 4
Jun 12, 2026Carr DouglasSVP Finance & OperationsSale1,654$3.69KForm 4
Jun 12, 2026Russotti GregorySee RemarksSale2,584$5.77KForm 4
Jun 11, 2026Cowan ChadChief Scientific OfficerTax withholding358$801.92Form 4
Jun 11, 2026Pfeiffenberger BrentPresident and CEOTax withholding13,849$31.02KForm 4
Jun 8, 2026Carr DouglasSVP Finance & OperationsSale249$525.64Form 4
Jun 8, 2026Russotti GregorySee RemarksSale524$1.11KForm 4
Jun 5, 2026Pfeiffenberger BrentPresident and CEOTax withholding463$986.19Form 4
May 15, 2026Pfeiffenberger BrentPresident and CEOTax withholding31,172$72.94KForm 4
May 4, 2026Carr DouglasSVP Finance & OperationsSale264$618.02Form 4
Apr 1, 2026Cowan ChadChief Scientific OfficerTax withholding1,365$2.99KForm 4
Mar 12, 2026Russotti GregorySee RemarksSale10,076$25.68KForm 4
Mar 12, 2026Carr DouglasSVP Finance & OperationsSale7,043$17.95KForm 4
Mar 11, 2026Cowan ChadChief Scientific OfficerTax withholding1,431$3.91KForm 4
Mar 11, 2026Pfeiffenberger BrentPresident and CEOTax withholding55,397$151.23KForm 4
Mar 9, 2026Russotti GregorySee RemarksSale479$1.21KForm 4
Mar 9, 2026Carr DouglasSVP Finance & OperationsSale247$626.39Form 4
Mar 6, 2026Pfeiffenberger BrentPresident and CEOTax withholding463$1.19KForm 4
Feb 13, 2026Pfeiffenberger BrentPresident and CEOTax withholding31,172$54.55KForm 4
Feb 3, 2026Carr DouglasSVP Finance & OperationsSale323$588.51Form 4
Feb 2, 2026Carr DouglasSVP Finance & OperationsAward110,000—Form 4
Feb 2, 2026Russotti GregorySee RemarksAward135,000—Form 4
Feb 2, 2026Pfeiffenberger BrentPresident and CEOAward475,000—Form 4
Feb 2, 2026Cowan ChadChief Scientific OfficerAward135,000—Form 4
Jan 2, 2026Cowan ChadChief Scientific OfficerTax withholding1,611$1.60KForm 4
Dec 22, 2025Cowan ChadChief Scientific OfficerBuy58,060$49.25KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related